Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inhaled nitric oxide reduces human lung allograft dysfunction

H Date1, A N Triantafillou, E P Trulock

  • 1Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA.

The Journal of Thoracic and Cardiovascular Surgery
|May 1, 1996
PubMed
Summary

Inhaled nitric oxide (NO) improves oxygenation and reduces pulmonary hypertension in lung transplant recipients with severe graft dysfunction. NO therapy also decreased mechanical ventilation duration, airway complications, and mortality.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anonymous leadership and stochastic resonance in collectives of self-propelled robots.

Physical review. E·2026
Same author

Pressure dynamics in the bottleneck flow of self-propelled particles.

Physical review. E·2026
Same author

Experimental and numerical study of a second-order transition in the behavior of confined self-propelled particles.

Physical review. E·2024
Same author

Bistability in orbital trajectories of a chiral self-propelled particle interacting with an external field.

Physical review. E·2022
Same author

Properties of balanced flows with bottlenecks: Common stylized facts in finance and vibration-driven vehicles.

Physical review. E·2020
Same author

Clogging Transition of Vibration-Driven Vehicles Passing through Constrictions.

Physical review letters·2017

Area of Science:

  • Cardiology
  • Pulmonology
  • Transplantation Medicine

Background:

  • Severe graft dysfunction, characterized by hypoxia and pulmonary hypertension, affects 10-20% of lung transplant recipients.
  • Early identification and management of graft dysfunction are critical for patient outcomes.

Purpose of the Study:

  • To investigate the efficacy of inhaled nitric oxide (NO) in mitigating early severe human lung allograft dysfunction.
  • To compare postoperative hemodynamic data, gas exchange, and clinical outcomes in lung transplant recipients with graft dysfunction treated with or without NO.

Main Methods:

  • Retrospective analysis of 243 adult lung transplant recipients, identifying 32 with immediate severe allograft dysfunction (PaO2/FiO2 ratio <150).
  • Group 1 (n=17) received conventional treatment; Group 2 (n=15) received inhaled NO (20-60 ppm for average 84 hours) upon diagnosis of dysfunction.

Related Experiment Videos

Main Results:

  • Inhaled NO significantly improved oxygenation (PaO2/FiO2 ratio from 88 to 153) and reduced pulmonary artery pressure (from 30 to 26 mm Hg) within 1 hour.
  • NO therapy was associated with a shorter duration of mechanical ventilation (12 vs. 17 days), fewer airway complications, and reduced mortality (7% vs. 24%) compared to conventional treatment.
  • No significant changes in mean arterial pressure or cardiac index were observed; transient methemoglobinemia occurred in two patients without associated complications.

Conclusions:

  • Inhaled nitric oxide is effective in improving oxygenation and decreasing pulmonary artery pressure in lung transplant recipients with severe allograft dysfunction.
  • NO therapy offers potential benefits including reduced mechanical ventilation time, fewer airway complications, and lower mortality rates in this patient population.